You are here: Industry Insights > Bryostatin-1

News List

BryoLogyx Completes World’s First GMP Synthesis of Bryostatin-1 contractpharma
October 15, 2020
BryoLogyx has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good Manufacturing Practice (GMP) regulations.
BryoLogyx Acquires Rights to Neurotrope’s Bryostatin-1 contractpharma
June 16, 2020
Bryostatin-1 will be chemically synthesized by Albany Molecular Research Inc. (AMRI) in collaboration with BryoLogyx.
Bryostatin-1 Study Does Not Meet Primary Endpoint americanpharmaceuticalreview
September 10, 2019
Neurotrope announced its confirmatory Phase 2 study of Bryostatin-1 in moderate to severe AD did not achieve statistical significance on the primary endpoint...
Neurotrope Announces Agreement for Bryostatin-1 with National Cancer Institute americanpharmaceuticalreview
February 19, 2019
Neurotrope has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for the research and clinical development of Bryostatin-1.....